BAY1454032, Essure System for Permanent Birth Control
Research payments
$963,366
Through program year 2023, $963,366 in research payments was reported against BAY1454032, Essure System for Permanent Birth Control, across 361 payments, paid by Bayer HealthCare Pharmaceuticals Inc..
- Paid by
- Bayer HealthCare Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $402,589 | 163 |
| 2022 | Research | $560,778 | 198 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Howard Eisenberg Tucson, AZ Named on 22 payments
- Linda-Dalal Shiber Cleveland, OH Named on 16 payments
- Kelle Oberle Lakewood, CO Named on 14 payments
- Gerard Reilly Cincinnati, OH Named on 13 payments
- Mark Martens Reading, PA Named on 11 payments
- Kenneth Deck Laguna Hills, CA Named on 11 payments
- John Whitfield Fort Worth, TX Named on 10 payments
- Cindy Basinski Newburgh, IN Named on 10 payments
- Stephen Fehnel West Reading, PA Named on 10 payments
- Paula Castano New York, NY Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.